Cellectar Biosciences, Inc. (CLRB)
3.15
+0.06
(+1.94%)
USD |
NASDAQ |
May 18, 13:49
Cellectar Biosciences Shareholders Equity (Quarterly) : 4.717M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Karyopharm Therapeutics, Inc. | -265.65M |
| Ocugen, Inc. | 5.805M |
| Invivyd, Inc. | 203.05M |
| ACADIA Pharmaceuticals, Inc. | 1.248B |
| Alnylam Pharmaceuticals, Inc. | 1.075B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 11.12M |
| Total Liabilities (Quarterly) | 6.403M |
| Debt to Equity Ratio | 0.3241 |
| Current Ratio | 1.901 |
| Net Debt Paydown Yield | -1.92% |